(+)-catechin decreases expression ISO RGD:735682 6480464 Catechin results in decreased expression of NPM1 mRNA CTD PMID:15465739 (1->4)-beta-D-glucan multiple interactions ISO RGD:11000 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NPM1 mRNA CTD PMID:36331819 1,2-dichloroethane decreases expression ISO RGD:11000 6480464 ethylene dichloride results in decreased expression of NPM1 mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO RGD:11000 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NPM1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:11000 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of NPM1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of NPM1 mRNA CTD PMID:17108234 17beta-estradiol increases expression ISO RGD:735682 6480464 Estradiol results in increased expression of NPM1 mRNA CTD PMID:16514628 17beta-estradiol decreases phosphorylation ISO RGD:735682 6480464 Estradiol results in decreased phosphorylation of NPM1 protein CTD PMID:27026707 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:20056577 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:11000 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:11000 6480464 Tetrachlorodibenzodioxin results in decreased expression of NPM1 mRNA CTD PMID:16962184 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of NPM1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of NPM1 mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:11000 6480464 Tetrachlorodibenzodioxin affects the expression of NPM1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NPM1 protein CTD PMID:16548065 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:11000 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of NPM1 mRNA CTD PMID:17942748 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of NPM1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of NPM1 mRNA CTD PMID:21346803 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of NPM1 mRNA CTD PMID:15890375 3,3',5,5'-tetrabromobisphenol A affects localization ISO RGD:735682 6480464 tetrabromobisphenol A affects the localization of NPM1 protein CTD PMID:27998958 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of NPM1 protein CTD PMID:34915118 4,4'-diaminodiphenylmethane decreases expression ISO RGD:11000 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of NPM1 mRNA CTD PMID:18648102 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of NPM1 mRNA CTD PMID:30723492 4,4'-sulfonyldiphenol affects localization ISO RGD:735682 6480464 bis(4-hydroxyphenyl)sulfone affects the localization of NPM1 protein CTD PMID:27998958 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of NPM1 mRNA CTD PMID:36041667 4,4'-sulfonyldiphenol increases expression ISO RGD:735682 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of NPM1 protein CTD PMID:34186270 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NPM1 mRNA CTD PMID:15890375 5-aza-2'-deoxycytidine decreases methylation ISO RGD:735682 6480464 Decitabine results in decreased methylation of NPM1 promoter CTD PMID:18055864 5-fluorouracil decreases response to substance ISO RGD:735682 6480464 NPM1 protein results in decreased susceptibility to Fluorouracil CTD PMID:24736981 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of NPM1 mRNA CTD PMID:30047161 9-cis-retinoic acid decreases expression ISO RGD:735682 6480464 Alitretinoin results in decreased expression of NPM1 protein CTD PMID:28886987 afimoxifene decreases expression ISO RGD:735682 6480464 afimoxifene results in decreased expression of NPM1 mRNA CTD PMID:16514628 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of NPM1 mRNA CTD PMID:15890375 aflatoxin B1 decreases methylation ISO RGD:735682 6480464 Aflatoxin B1 results in decreased methylation of NPM1 gene CTD PMID:27153756 all-trans-retinoic acid multiple interactions ISO RGD:735682 6480464 Tretinoin promotes the reaction [[NPM1 protein binds to TFAP2A protein] which binds to NPM1 promoter], Tretinoin promotes the reaction [NPM1 protein binds to TFAP2A protein] CTD PMID:17318229 all-trans-retinoic acid decreases expression ISO RGD:735682 6480464 Tretinoin results in decreased expression of NPM1 mRNA, Tretinoin results in decreased expression of NPM1 protein CTD PMID:17318229 more ... ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of NPM1 mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO RGD:735682 6480464 aristolochic acid I results in decreased expression of NPM1 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:11000 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of NPM1 mRNA CTD PMID:23650126 arsane increases expression ISO RGD:735682 6480464 Arsenic results in increased expression of NPM1 mRNA, Arsenic results in increased expression of NPM1 protein CTD PMID:19818359 arsane affects methylation ISO RGD:735682 6480464 Arsenic affects the methylation of NPM1 gene CTD PMID:25304211 arsenic atom increases expression ISO RGD:735682 6480464 Arsenic results in increased expression of NPM1 mRNA, Arsenic results in increased expression of NPM1 protein CTD PMID:19818359 arsenic atom affects methylation ISO RGD:735682 6480464 Arsenic affects the methylation of NPM1 gene CTD PMID:25304211 arsenous acid multiple interactions ISO RGD:735682 6480464 Acetylcysteine inhibits the reaction [NPM1 protein mutant form results in increased susceptibility to Arsenic Trioxide] CTD PMID:23877794 arsenous acid affects response to substance ISO RGD:735682 6480464 NPM1 protein affects the susceptibility to Arsenic Trioxide CTD PMID:23877794 arsenous acid increases response to substance ISO RGD:735682 6480464 NPM1 protein mutant form results in increased susceptibility to Arsenic Trioxide CTD PMID:23877794 arsenous acid increases expression ISO RGD:735682 6480464 Arsenic Trioxide results in increased expression of NPM1 mRNA CTD PMID:20458559 , PMID:22521957 Benoxacor decreases expression ISO RGD:11000 6480464 benoxacor results in decreased expression of NPM1 mRNA CTD PMID:34850242 benzo[a]pyrene increases expression ISO RGD:735682 6480464 Benzo(a)pyrene results in increased expression of NPM1 mRNA CTD PMID:21714911 benzo[a]pyrene increases expression ISO RGD:11000 6480464 Benzo(a)pyrene results in increased expression of NPM1 mRNA CTD PMID:22228805 bis(2-chloroethyl) sulfide increases expression ISO RGD:735682 6480464 Mustard Gas results in increased expression of NPM mRNA CTD PMID:12884408 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of NPM1 promoter CTD PMID:23359474 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of NPM1 mRNA, [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of NPM1 promoter CTD PMID:23359474 , PMID:36041667 bisphenol A decreases expression ISO RGD:735682 6480464 bisphenol A results in decreased expression of NPM1 protein CTD PMID:34186270 bisphenol A decreases expression ISO RGD:11000 6480464 bisphenol A results in decreased expression of NPM1 mRNA CTD PMID:33221593 bisphenol A affects expression ISO RGD:735682 6480464 bisphenol A affects the expression of NPM1 mRNA CTD PMID:30903817 bisphenol A affects localization ISO RGD:735682 6480464 bisphenol A affects the localization of NPM1 protein, bisphenol A analog affects the localization of NPM1 protein CTD PMID:27998958 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NPM1 mRNA CTD PMID:25181051 Bisphenol B increases expression ISO RGD:735682 6480464 bisphenol B results in increased expression of NPM1 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:735682 6480464 bisphenol F results in increased expression of NPM1 protein CTD PMID:34186270 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of NPM1 mRNA CTD PMID:36041667 bleomycin A2 increases expression EXP 6480464 Bleomycin results in increased expression of NPM1 protein CTD PMID:25933445 bortezomib multiple interactions ISO RGD:735682 6480464 Acetylcysteine inhibits the reaction [NPM1 protein mutant form results in increased susceptibility to Bortezomib] CTD PMID:23877794 bortezomib affects response to substance ISO RGD:735682 6480464 NPM1 protein affects the susceptibility to Bortezomib CTD PMID:23877794 bortezomib increases response to substance ISO RGD:735682 6480464 NPM1 protein mutant form results in increased susceptibility to Bortezomib CTD PMID:23877794 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of NPM1 mRNA CTD PMID:12628495 busulfan multiple interactions ISO RGD:735682 6480464 NPM1 gene mutant form results in increased susceptibility to [Busulfan co-treated with Idarubicin] CTD PMID:20172040 butyric acid decreases expression EXP 6480464 Butyric Acid results in decreased expression of NPM1 mRNA CTD PMID:12800193 cadmium atom multiple interactions ISO RGD:735682 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NPM1 protein CTD PMID:33040242 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of NPM1 mRNA CTD PMID:33453195 cadmium dichloride multiple interactions ISO RGD:735682 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NPM1 protein CTD PMID:33040242 caffeine decreases phosphorylation ISO RGD:735682 6480464 Caffeine results in decreased phosphorylation of NPM1 protein CTD PMID:35688186 calcitriol multiple interactions ISO RGD:735682 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of NPM1 mRNA CTD PMID:21592394 calcitriol decreases expression ISO RGD:735682 6480464 Calcitriol results in decreased expression of NPM1 mRNA CTD PMID:21592394 carbon nanotube increases expression ISO RGD:11000 6480464 Nanotubes more ... CTD PMID:25554681 chlorpyrifos decreases expression ISO RGD:11000 6480464 Chlorpyrifos results in decreased expression of NPM1 mRNA CTD PMID:37019170 chromium(6+) affects expression ISO RGD:11000 6480464 chromium hexavalent ion affects the expression of NPM1 mRNA CTD PMID:28472532 chrysene increases expression ISO RGD:11000 6480464 chrysene results in increased expression of NPM1 mRNA CTD PMID:26377693 cisplatin increases expression ISO RGD:735682 6480464 Cisplatin results in increased expression of NPM1 protein CTD PMID:19818359 cisplatin decreases response to substance ISO RGD:735682 6480464 NPM1 protein results in decreased susceptibility to Cisplatin CTD PMID:24736981 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of NPM1 mRNA CTD PMID:17602206 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of NPM1 mRNA CTD PMID:17602206 copper(II) sulfate decreases expression ISO RGD:735682 6480464 Copper Sulfate results in decreased expression of NPM1 mRNA CTD PMID:19549813 coumarin increases phosphorylation ISO RGD:735682 6480464 coumarin results in increased phosphorylation of NPM1 protein CTD PMID:35688186 CU-O LINKAGE increases phosphorylation ISO RGD:735682 6480464 cupric oxide results in increased phosphorylation of NPM1 protein CTD PMID:25470785 deguelin multiple interactions ISO RGD:735682 6480464 [NPM1 protein mutant form results in increased susceptibility to deguelin] which results in decreased expression of and results in increased activity of CASP6 protein more ... CTD PMID:25242579 deguelin increases response to substance ISO RGD:735682 6480464 NPM1 protein mutant form results in increased susceptibility to deguelin CTD PMID:25242579 deguelin decreases expression ISO RGD:735682 6480464 [deguelin results in decreased expression of NPM1 protein mutant form] which results in decreased expression of CDKN1A protein more ... CTD PMID:25242579 deoxynivalenol increases phosphorylation ISO RGD:11000 6480464 deoxynivalenol results in increased phosphorylation of NPM1 protein CTD PMID:23811945 diarsenic trioxide affects response to substance ISO RGD:735682 6480464 NPM1 protein affects the susceptibility to Arsenic Trioxide CTD PMID:23877794 diarsenic trioxide increases response to substance ISO RGD:735682 6480464 NPM1 protein mutant form results in increased susceptibility to Arsenic Trioxide CTD PMID:23877794 diarsenic trioxide increases expression ISO RGD:735682 6480464 Arsenic Trioxide results in increased expression of NPM1 mRNA CTD PMID:20458559 , PMID:22521957 diarsenic trioxide multiple interactions ISO RGD:735682 6480464 Acetylcysteine inhibits the reaction [NPM1 protein mutant form results in increased susceptibility to Arsenic Trioxide] CTD PMID:23877794 diazinon affects expression EXP 6480464 Diazinon affects the expression of NPM1 mRNA CTD PMID:22546817 dibutyl phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of NPM1 promoter CTD PMID:23359474 dicrotophos decreases expression ISO RGD:735682 6480464 dicrotophos results in decreased expression of NPM1 mRNA CTD PMID:28302478 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of NPM1 mRNA CTD PMID:22546817 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of NPM1 mRNA CTD PMID:15890375 dihydroartemisinin affects binding ISO RGD:735682 6480464 artenimol analog binds to NPM1 protein CTD PMID:26340163 doxorubicin decreases response to substance ISO RGD:735682 6480464 NPM1 protein results in decreased susceptibility to Doxorubicin CTD PMID:24736981 elemental selenium multiple interactions EXP 6480464 [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of NPM1 mRNA CTD PMID:11444866 enzyme inhibitor multiple interactions ISO RGD:735682 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NPM1 protein CTD PMID:23301498 ethanol affects splicing ISO RGD:11000 6480464 Ethanol affects the splicing of NPM1 mRNA CTD PMID:30319688 fenthion increases expression ISO RGD:11000 6480464 Fenthion results in increased expression of NPM1 mRNA CTD PMID:34813904 flavonoids decreases expression ISO RGD:735682 6480464 Flavonoids results in decreased expression of NPM1 mRNA CTD PMID:15465739 flutamide increases expression EXP 6480464 Flutamide results in increased expression of NPM1 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:11000 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NPM1 mRNA CTD PMID:22206623 fulvestrant decreases expression ISO RGD:735682 6480464 fulvestrant results in decreased expression of NPM1 mRNA CTD PMID:16514628 furan increases methylation EXP 6480464 furan results in increased methylation of NPM1 gene CTD PMID:22079235 gemcitabine decreases response to substance ISO RGD:735682 6480464 NPM1 protein results in decreased susceptibility to Gemcitabine CTD PMID:24736981 genistein multiple interactions ISO RGD:735682 6480464 ESR1 promotes the reaction [Genistein results in increased expression of NPM1 protein], ESR2 promotes the reaction [Genistein results in increased expression of NPM1 protein] CTD PMID:20884965 genistein increases expression ISO RGD:735682 6480464 Genistein results in increased expression of NPM1 protein CTD PMID:20884965 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of NPM1 mRNA CTD PMID:22061828 geraniol decreases expression ISO RGD:735682 6480464 geraniol results in decreased expression of NPM1 mRNA CTD PMID:27683099 glafenine increases expression EXP 6480464 Glafenine results in increased expression of NPM1 mRNA CTD PMID:24136188 gold atom decreases expression ISO RGD:735682 6480464 Gold results in decreased expression of NPM1 mRNA CTD PMID:25523186 gold(0) decreases expression ISO RGD:735682 6480464 Gold results in decreased expression of NPM1 mRNA CTD PMID:25523186 idarubicin multiple interactions ISO RGD:735682 6480464 NPM1 gene mutant form results in increased susceptibility to [Busulfan co-treated with Idarubicin] CTD PMID:20172040 indometacin decreases expression ISO RGD:735682 6480464 Indomethacin results in decreased expression of NPM1 mRNA CTD PMID:10619186 isoflavones decreases expression ISO RGD:735682 6480464 Isoflavones results in decreased expression of NPM1 protein CTD PMID:19818359 isoprenaline decreases expression ISO RGD:11000 6480464 Isoproterenol results in decreased expression of NPM1 mRNA CTD PMID:21335049 ivermectin decreases expression ISO RGD:735682 6480464 Ivermectin results in decreased expression of NPM1 protein CTD PMID:32959892 josamycin affects response to substance ISO RGD:735682 6480464 NPM1 protein affects the susceptibility to Josamycin CTD PMID:31915244 L-ascorbic acid increases expression ISO RGD:11000 6480464 Ascorbic Acid results in increased expression of NPM1 mRNA CTD PMID:22139585 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of NPM1 mRNA CTD PMID:22641619 lipopolysaccharide multiple interactions ISO RGD:735682 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of NPM1 mRNA CTD PMID:35877022 melatonin multiple interactions ISO RGD:11000 6480464 Melatonin inhibits the reaction [NPM1 protein binds to NEDD4 protein] CTD PMID:31325559 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of NPM1 mRNA CTD PMID:15890375 methidathion increases expression ISO RGD:11000 6480464 methidathion results in increased expression of NPM1 mRNA CTD PMID:34813904 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of NPM1 mRNA CTD PMID:30047161 methotrexate increases expression ISO RGD:735682 6480464 Methotrexate results in increased expression of NPM1 mRNA, Methotrexate results in increased expression of NPM1 protein CTD PMID:24736981 methotrexate decreases response to substance ISO RGD:735682 6480464 NPM1 protein results in decreased susceptibility to Methotrexate CTD PMID:24736981 methyl methanesulfonate decreases expression ISO RGD:735682 6480464 Methyl Methanesulfonate results in decreased expression of NPM1 mRNA CTD PMID:23649840 methylparaben decreases expression ISO RGD:735682 6480464 methylparaben results in decreased expression of NPM1 mRNA CTD PMID:31745603 methylparaben increases expression ISO RGD:735682 6480464 methylparaben results in increased expression of NPM1 mRNA CTD PMID:31745603 Monobutylphthalate decreases expression ISO RGD:11000 6480464 monobutyl phthalate results in decreased expression of NPM1 protein CTD PMID:20553848 N-(6-acetamidohexyl)acetamide decreases expression ISO RGD:735682 6480464 hexamethylene bisacetamide results in decreased expression of NPM1 protein CTD PMID:17569113 N-acetyl-L-cysteine multiple interactions ISO RGD:735682 6480464 Acetylcysteine inhibits the reaction [NPM1 protein mutant form results in increased susceptibility to arsenic trioxide], Acetylcysteine inhibits the reaction [NPM1 protein mutant form results in increased susceptibility to Bortezomib] CTD PMID:23877794 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of NPM1 mRNA, [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of NPM1 mRNA CTD PMID:17602206 , PMID:28943392 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of NPM1 mRNA CTD PMID:15890375 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of NPM1 mRNA CTD PMID:24136188 nocodazole affects phosphorylation ISO RGD:735682 6480464 Nocodazole affects the phosphorylation of NPM1 protein CTD PMID:15190079 NSC 23766 affects response to substance ISO RGD:735682 6480464 NPM1 protein affects the susceptibility to NSC 23766 CTD PMID:36009428 ochratoxin A increases expression ISO RGD:11000 6480464 ochratoxin A results in increased expression of NPM1 protein CTD PMID:19445961 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of NPM1 mRNA CTD PMID:23358140 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NPM1 mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of NPM1 mRNA CTD PMID:25729387 paclitaxel decreases response to substance ISO RGD:735682 6480464 NPM1 protein results in decreased susceptibility to Paclitaxel CTD PMID:24736981 paracetamol affects expression ISO RGD:11000 6480464 Acetaminophen affects the expression of NPM1 mRNA CTD PMID:17562736 paraquat increases expression EXP 6480464 Paraquat results in increased expression of NPM1 mRNA CTD PMID:32680482 parathion increases expression ISO RGD:11000 6480464 Parathion results in increased expression of NPM1 mRNA CTD PMID:34813904 pemetrexed decreases response to substance ISO RGD:735682 6480464 NPM1 protein results in decreased susceptibility to Pemetrexed CTD PMID:24736981 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:11000 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NPM1 mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NPM1 mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of NPM1 mRNA CTD PMID:19162173 , PMID:21318169 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of NPM1 mRNA CTD PMID:15215175 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of NPM1 mRNA CTD PMID:15890375 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of NPM1 mRNA CTD PMID:15890375 more ... pirinixic acid increases expression ISO RGD:11000 6480464 pirinixic acid results in increased expression of NPM1 mRNA CTD PMID:23811191 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of NPM1 mRNA CTD PMID:30047161 quercetin decreases expression ISO RGD:735682 6480464 Quercetin results in decreased expression of NPM1 protein CTD PMID:19207037 quercetin decreases phosphorylation ISO RGD:735682 6480464 Quercetin results in decreased phosphorylation of NPM1 protein CTD PMID:35688186 raloxifene decreases expression ISO RGD:735682 6480464 Raloxifene Hydrochloride results in decreased expression of NPM1 mRNA CTD PMID:16514628 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of NPM1 protein CTD PMID:35544339 selenium atom multiple interactions EXP 6480464 [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of NPM1 mRNA CTD PMID:11444866 silicon dioxide affects secretion ISO RGD:735682 6480464 Silicon Dioxide analog affects the secretion of NPM1 protein CTD PMID:25895662 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of NPM1 mRNA CTD PMID:22431001 silicon dioxide increases expression ISO RGD:735682 6480464 Silicon Dioxide analog results in increased expression of NPM1 mRNA CTD PMID:25895662 sodium arsenite increases expression ISO RGD:735682 6480464 sodium arsenite results in increased expression of NPM1 protein CTD PMID:21925251 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of NPM1 mRNA CTD PMID:22561333 , PMID:25993096 Soman increases expression EXP 6480464 Soman results in increased expression of NPM1 mRNA CTD PMID:19281266 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of NPM1 mRNA CTD PMID:30047161 sunitinib increases expression ISO RGD:735682 6480464 Sunitinib results in increased expression of NPM1 mRNA CTD PMID:31533062 T-2 toxin affects expression EXP 6480464 T-2 Toxin affects the expression of NPM1 protein CTD PMID:26141394 testosterone decreases expression ISO RGD:735682 6480464 Testosterone results in decreased expression of NPM1 mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:735682 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of NPM1 mRNA CTD PMID:21592394 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of NPM1 mRNA CTD PMID:15963342 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of NPM1 mRNA CTD PMID:28943392 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of NPM1 mRNA CTD PMID:34492290 titanium dioxide increases phosphorylation ISO RGD:735682 6480464 titanium dioxide results in increased phosphorylation of NPM1 protein CTD PMID:21439344 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NPM1 mRNA CTD PMID:25729387 Tributyltin oxide decreases expression EXP 6480464 bis(tri-n-butyltin)oxide results in decreased expression of NPM1 mRNA CTD PMID:17553608 Tributyltin oxide increases phosphorylation ISO RGD:11000 6480464 bis(tri-n-butyltin)oxide results in increased phosphorylation of NPM1 protein CTD PMID:22174045 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of NPM1 gene CTD PMID:27618143 trimellitic anhydride increases expression ISO RGD:11000 6480464 trimellitic anhydride results in increased expression of NPM1 mRNA CTD PMID:19042947 triphenylstannane increases expression ISO RGD:735682 6480464 triphenyltin analog results in increased expression of NPM1 protein CTD PMID:31634547 triptonide decreases expression ISO RGD:11000 6480464 triptonide results in decreased expression of NPM1 mRNA CTD PMID:33045310 troglitazone multiple interactions ISO RGD:735682 6480464 [RARA gene mutant form co-treated with NPM1 gene mutant form] affects the susceptibility to troglitazone CTD PMID:14508522 tungsten increases expression ISO RGD:11000 6480464 Tungsten results in increased expression of NPM1 mRNA CTD PMID:30912803 valproic acid decreases expression ISO RGD:735682 6480464 Valproic Acid results in decreased expression of NPM1 mRNA CTD PMID:23179753 , PMID:27188386 vancomycin decreases expression ISO RGD:11000 6480464 Vancomycin results in decreased expression of NPM1 mRNA CTD PMID:18930951 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of NPM1 mRNA CTD PMID:22570695 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of NPM1 mRNA CTD PMID:23034163 vinorelbine decreases response to substance ISO RGD:735682 6480464 NPM1 protein results in decreased susceptibility to vinorelbine CTD PMID:24736981 vitamin E multiple interactions EXP 6480464 [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of NPM1 mRNA CTD PMID:11444866 zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of NPM1 mRNA CTD PMID:16140947 zinc atom multiple interactions EXP 6480464 Zinc inhibits the reaction [Zinc deficiency results in increased expression of NPM1 mRNA] CTD PMID:16140947 zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of NPM1 mRNA CTD PMID:16140947 zinc(0) multiple interactions EXP 6480464 Zinc inhibits the reaction [Zinc deficiency results in increased expression of NPM1 mRNA] CTD PMID:16140947
